Sign In

Margaret Sampson

Partner at McDermott Will & Emery

Margaret J. Sampson, Ph.D., is a Partner at McDermott Will & Emery, a prestigious law firm.1 She specializes in global, strategic intellectual property transactions and patent counseling, particularly in the areas of life sciences, pharmaceuticals, research tools, and medical devices.1

Professional Background

Dr. Sampson's practice focuses on:

  1. Evaluating and structuring major transactions
  2. Analyzing freedom-to-operate issues
  3. Identifying potential investment targets
  4. Hatch-Waxman patent litigation
  5. Patent term extensions and adjustments
  6. Patent office proceedings1

She is highly skilled in various transactions, including licensing agreements, development and collaboration agreements, clinical research agreements, and royalty monetization transactions.1

Education and Research

Dr. Sampson holds a Ph.D. and has a significant research background in:

  • Molecular genetics
  • Recombinant DNA
  • Stem cell research

Her research experience includes creating mouse knock-out models to better understand gene function in organisms.1

Legal Education

During her time in law school, Dr. Sampson served as the editor-in-chief of the Texas Intellectual Property Law Journal.1

Recognition and Awards

Dr. Sampson has received numerous accolades for her work, including:

  • Recommended Lawyer by Legal 500 (2023)
  • Listed in IAM Patent 1000 – The World's Leading Patent Practitioners (2023-2024)
  • Named in Best Lawyers in America for various categories (2012-2025)
  • Recognized as an IP Star by Managing Intellectual Property (2014-2017, 2024)
  • Named one of the Top 250 Women in IP by Managing Intellectual Property (2014-2017)
  • Selected as a Texas Super Lawyer by Thomson Reuters (2016-2018)
  • Named a BTI Client Service All-Star (2015)1

Dr. Sampson's LinkedIn profile confirms her current position as Partner at McDermott Will & Emery, and her location is listed as Austin.2

Highlights

Dec 3 · linkedin

In the keynote interview, Moving the Market with McDermott's Head of Investment Funds and Partner, Ian Schwartz, Ian discusses where LPs are choosing to allocate their capital given the challenging fundraising environment. He shares while blue chip firms are still having success in raising multi-billion-dollar funds as LPs feel more comfortable re-upping with managers they have known for years, LPs don't want to miss out on opportunities with emerging managers who may end up being the next great success story. Read Private Equity International’s full interview at the link below.

Dec 1 · linkedin

Join my colleagues to explore the latest developments and what’s to come in patent, trademark, copyright and trade secret law in our 2024 IP Outlook webinar. Gain valuable insights to help navigate the evolving #intellectualproperty landscape and shape your business strategy for success in 2024.

Register today through the link below!

Related Questions

What are some notable cases Margaret Sampson has worked on?
How did Margaret Sampson transition from molecular genetics research to IP law?
What makes Margaret Sampson's approach to IP transactions unique?
Can you provide examples of Margaret Sampson's work in the life sciences sector?
What awards and recognitions has Margaret Sampson received in her career?
M
Add to my network

Location

Austin, Texas, United States